Diagnosis and Management of Acanthosis Nigricans
Literature Review
DOI:
https://doi.org/10.55175/cdk.v53i04.1667Keywords:
Acanthosis nigricans, diabetes mellitus, obesity, insulin resistant, managementAbstract
Acanthosis nigricans (AN) is a skin disorder characterized by hyperpigmented, thickened, and velvety lesions, primarily affecting intertriginous areas. This condition is commonly associated with insulin resistance, diabetes mellitus, obesity, endocrine disorders, and the use of certain medications, and in some cases may serve as a marker of underlying internal malignancy. Individuals with darker skin are more prone to developing AN. Although it can be present at birth, AN is more commonly observed in adults. This literature review aims to discuss the etiology, pathomechanism, clinical manifestations, diagnostic approach, and management of acanthosis nigricans, with emphasis on its role as an indicator of underlying systemic disease. Literature was obtained from various relevant scientific sources, including review articles, case reports, and clinical studies. The pathogenesis of AN is primarily associated with hyperinsulinemia, which stimulates keratinocyte and fibroblast proliferation through the insulin-like growth factor-1 (IGF-1) pathway. Diagnosis is generally established clinically, although laboratory and histopathological evaluations may be required in certain cases. Management focuses on treating the underlying condition, such as weight reduction, improvement of insulin resistance, and management of malignancy when present, along with topical or procedural therapies to improve skin lesions and patients’ quality of life.
Downloads
References
Salati SA. Acanthosis nigricans: an extensive review. J Pak Assoc Dermatol. 2021;31(4):273–88. https://doi.org/10.66344/jpad.31.2.2021.1556.
Darhous SA, Eldeeb F. Acanthosis nigricans, insight about management: review article. Egypt J Hosp Med. 2023;90(2):3649–53. doi:10.21608/ejhm.2023.292768.
Fanning E, O'Shea D. Genetics and the metabolic syndrome. Clin Dermatol. 2018;36(1):9–13. doi:10.1016/j.clindermatol.2017.09.004.
Popa ML, Ilie MA, Purcarea A, Sandru F, Dumitrascu MC, Hasan AE, et al. Acanthosis nigricans: to be or not to be afraid. Oncol Lett. 2019;17(5):4133–8. doi:10.3892/ol.2018.9736.
Sturner RA, Denning S, Marchase P. Acanthosis nigricans and autoimmune reactivity. JAMA. 1981;246(7):763–5. doi:10.1001/jama.1981.03320070041021.
Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994;31(1):1–22. doi:10.1016/s0190-9622(94)70128-8.
Erickson L, Lipschutz DE, Wrigley W, Kearse WO. A peculiar cutaneous reaction to repeated injections of insulin. JAMA. 1969;209(6):934–5.
Sawatkar GU, Dogra S, Bhadada SK, Kanwar AJ. Acanthosis nigricans - an uncommon cutaneous adverse effect of a common medication: report of two cases. Indian J Dermatol Venereol Leprol. 2013;79(4):553. doi:10.4103/0378-6323.113105.
Bishnoi A, Parsad D. Velvety hyperpigmentation on hands and feet of a young girl: acral acanthosis nigricans. J Cutan Med Surg. 2018;22(3):323. doi:10.1177/1203475417740263.
Phiske MM. An approach to acanthosis nigricans. Indian Dermatol Online J. 2014;5(3):239–49. doi:10.4103/2229-5178.137765.
Radu AM, Carsote M, Dumitrascu MC, Sandru F. Acanthosis nigricans: pointer of endocrine entities. Diagnostics (Basel). 2022;12(10):2519. doi:10.3390/diagnostics12102519.
Barbato MT, Criado PR, da Silva AK, Averbeck E, Guerine MB, de Sa NB. Association of acanthosis nigricans and skin tags with insulin resistance. An Bras Dermatol. 2012;87(1):97–104. doi:10.1590/s0365-05962012000100013.
Lee HW, Suh HS, Choi JC, Lee MW, Choi JH, Moon KC, et al. Hyperkeratosis of the nipple and areola as a sign of malignant acanthosis nigricans. Clin Exp Dermatol. 2005;30(6):721–2. doi:10.1111/j.1365-2230.2005.01859.x.
Pardeshi SS, Khemani UN, Kamath RR, Kura MM, Jafferany M. Therapeutic implications of dermoscopic findings in acanthosis nigricans: a clinical and histopathological study. Dermatol Ther. 2020;33(6):e14521. doi:10.1111/dth.14521.
Tyebkhan G, Velaskar S, Yadav P, Phiske M, Shah D. An Indian expert group review of acanthosis nigricans with recommendations for early detection and timely management. J Assoc Physicians India. 2024;72(6):74–84. doi: 10.59556/japi.72.0569.
Das A, Datta D, Kassir M, Wollina U, Galadari H, Lotti T, et al. Acanthosis nigricans: a review. J Cosmet Dermatol. 2020;19(8):1857–65. doi:10.1111/jocd.13544.
Miller JH. Acanthosis nigricans. Medscape [Internet]. 2025 [cited 2024 Nov 25]. Available from: https://emedicine.medscape.com/article/1102488-overview.
Arellano J, Iglesias P, Suarez C, Corredoira Y, Schnettler K. Malignant acanthosis nigricans as a paraneoplastic manifestation of metastatic breast cancer. Int J Womens Dermatol. 2019;5(3):183–6. doi:10.1016/j.ijwd.2019.04.020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Benly Levi Andreas Sibarani, Putri Utami

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.






